| Filed On | Filing |
|---|---|
| 24 Jul 2025 |
Form 3: Averill Julianne, Director
No securities owned |
| 01 Sep 2023 |
Form 3: Frias Juan Pablo, Chief Medical Officer
No securities owned |
| 24 Jun 2022 |
Form 3: Faust Elizabeth, Director
No securities owned |
| 05 Aug 2021 |
Form 3: Valle Franco, Chief Financial Officer
No securities owned |
| 21 Jun 2021 |
Form 3: Ray Sumita, Director
No securities owned |
| 26 Apr 2021 |
Form 3: A2A Pharmaceuticals, Inc., 10% owner
Holds 4,365,342 shares of Common Stock |
| 15 Apr 2021 |
Form 3: Erdtmann Rainer M, Director
Holds 2,182,671 shares of Common Stock |
| 15 Apr 2021 |
Form 3: Butler Thomas Andrew, Director
Holds 2,182,671 shares of Common Stock |
| 15 Apr 2021 |
Form 3: Hitchcock Michael J.m., Director
No securities owned |
| 15 Apr 2021 |
Form 3: Ryan Sunny, EVP of Finance
Holds 63,114 shares of Common Stock |
| 15 Apr 2021 |
Form 3: Biomea Health, Llc, 10% owner
Holds 4,365,342 shares of Common Stock |
| 15 Apr 2021 |
Form 3: Aguiar Eric, Director
No securities owned |
| 15 Apr 2021 |
Form 3: Stergiopoulos Sotirios, Director
Holds 4,365,342 shares of Common |
| 15 Apr 2021 | Form 3: Chen Bihua, Director and 3 others |
Loading...